OUR EXPERT NETWORK

• Engineering CAR T Cells With mRNA-LNPs: Applying Oncology Learnings To Allergic Diseases

  Targeted lipid nanoparticles (LNPs) could deliver mRNA encoding a CAR directly to T cells inside a patient with allergic disease. The potential implications extend beyond a single allergic condition. 

• RNA Oligonucleotide Synthesis: How Advanced Manufacturing Technologies Are Accelerating Innovation

  From a tech perspective, the manufacturing objective is shifting toward integrated process optimization. Automated reaction control, multivariate analytics, and more can connect molecular quality with operational performance. 

• AI Agents Are Only As Good As The RNA Knowledge Behind Them

  The RNA field is producing extraordinary volumes of information. Yet, giving an AI system access to more information does not necessarily make the system more scientifically intelligent.

• Will 2027 See A Meteoric Rise Of Programmable Nanomedicine?

  The significance of programmable nanomedicines is not simply that nanoparticles can carry more functions. It is that biological information can become part of the control logic.

• From Cell State Reprogramming To The Clinic: Turning The Regulatory Genome Into RNA Medicines (Pt. 2)

  Ounzain discusses how regulatory genome biology is being translated into drug discovery, from identifying lncRNA targets to building clinically relevant therapeutics and more.